Checkpoint Therapeutics (CKPT) Competitors $4.18 +0.02 (+0.48%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$4.18 0.00 (-0.12%) As of 05/21/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CKPT vs. ANIP, SPRY, CALT, ETNB, AMPH, OCUL, BGM, AUPH, WVE, and GYREShould you be buying Checkpoint Therapeutics stock or one of its competitors? The main competitors of Checkpoint Therapeutics include ANI Pharmaceuticals (ANIP), ARS Pharmaceuticals (SPRY), Calliditas Therapeutics AB (publ) (CALT), 89bio (ETNB), Amphastar Pharmaceuticals (AMPH), Ocular Therapeutix (OCUL), Qilian International Holding Group (BGM), Aurinia Pharmaceuticals (AUPH), Wave Life Sciences (WVE), and Gyre Therapeutics (GYRE). These companies are all part of the "pharmaceutical products" industry. Checkpoint Therapeutics vs. ANI Pharmaceuticals ARS Pharmaceuticals Calliditas Therapeutics AB (publ) 89bio Amphastar Pharmaceuticals Ocular Therapeutix Qilian International Holding Group Aurinia Pharmaceuticals Wave Life Sciences Gyre Therapeutics Checkpoint Therapeutics (NASDAQ:CKPT) and ANI Pharmaceuticals (NASDAQ:ANIP) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, community ranking, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends. Which has higher valuation & earnings, CKPT or ANIP? ANI Pharmaceuticals has higher revenue and earnings than Checkpoint Therapeutics. ANI Pharmaceuticals is trading at a lower price-to-earnings ratio than Checkpoint Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCheckpoint Therapeutics$41K8,539.84-$51.85M-$1.29-3.24ANI Pharmaceuticals$674.07M1.90$18.78M-$1.27-46.52 Do institutionals & insiders hold more shares of CKPT or ANIP? 22.0% of Checkpoint Therapeutics shares are held by institutional investors. Comparatively, 76.1% of ANI Pharmaceuticals shares are held by institutional investors. 2.1% of Checkpoint Therapeutics shares are held by company insiders. Comparatively, 11.1% of ANI Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Do analysts recommend CKPT or ANIP? Checkpoint Therapeutics presently has a consensus price target of $4.33, indicating a potential upside of 3.67%. ANI Pharmaceuticals has a consensus price target of $80.13, indicating a potential upside of 35.62%. Given ANI Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe ANI Pharmaceuticals is more favorable than Checkpoint Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Checkpoint Therapeutics 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33ANI Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.00 Does the media favor CKPT or ANIP? In the previous week, ANI Pharmaceuticals had 14 more articles in the media than Checkpoint Therapeutics. MarketBeat recorded 14 mentions for ANI Pharmaceuticals and 0 mentions for Checkpoint Therapeutics. ANI Pharmaceuticals' average media sentiment score of 1.07 beat Checkpoint Therapeutics' score of 0.56 indicating that ANI Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Checkpoint Therapeutics Positive ANI Pharmaceuticals Positive Which has more volatility and risk, CKPT or ANIP? Checkpoint Therapeutics has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500. Comparatively, ANI Pharmaceuticals has a beta of 0.56, suggesting that its share price is 44% less volatile than the S&P 500. Does the MarketBeat Community believe in CKPT or ANIP? ANI Pharmaceuticals received 259 more outperform votes than Checkpoint Therapeutics when rated by MarketBeat users. However, 67.16% of users gave Checkpoint Therapeutics an outperform vote while only 64.19% of users gave ANI Pharmaceuticals an outperform vote. CompanyUnderperformOutperformCheckpoint TherapeuticsOutperform Votes18267.16% Underperform Votes8932.84% ANI PharmaceuticalsOutperform Votes44164.19% Underperform Votes24635.81% Is CKPT or ANIP more profitable? Checkpoint Therapeutics has a net margin of 0.00% compared to ANI Pharmaceuticals' net margin of -1.28%. ANI Pharmaceuticals' return on equity of 15.87% beat Checkpoint Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Checkpoint TherapeuticsN/A N/A -659.07% ANI Pharmaceuticals -1.28%15.87%6.88% SummaryANI Pharmaceuticals beats Checkpoint Therapeutics on 14 of the 19 factors compared between the two stocks. Get Checkpoint Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CKPT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CKPT vs. The Competition Export to ExcelMetricCheckpoint TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$350.13M$6.52B$5.37B$8.39BDividend YieldN/A2.65%5.22%4.10%P/E Ratio-2.278.9226.8419.71Price / Sales8,539.84253.80392.34117.39Price / CashN/A65.8538.2534.62Price / Book-8.896.466.794.50Net Income-$51.85M$143.98M$3.23B$248.18M7 Day Performance0.72%2.03%1.53%0.20%1 Month Performance3.47%4.11%10.05%12.37%1 Year Performance125.95%-2.87%16.71%7.04% Checkpoint Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CKPTCheckpoint Therapeutics2.0391 of 5 stars$4.18+0.5%$4.33+3.7%+110.1%$350.13M$41,000.00-2.2710News CoveragePositive NewsANIPANI Pharmaceuticals4.8258 of 5 stars$62.30-6.0%$80.13+28.6%-4.3%$1.36B$614.38M-113.27600High Trading VolumeSPRYARS Pharmaceuticals2.4068 of 5 stars$13.29-1.1%$31.00+133.3%+61.0%$1.31B$89.15M-26.0690Trending NewsAnalyst RevisionCALTCalliditas Therapeutics AB (publ)N/A$40.00flat$39.25-1.9%N/A$1.19B$1.60B-21.62180ETNB89bio2.7432 of 5 stars$8.11+5.3%$27.25+236.0%+7.4%$1.18BN/A-2.7940Positive NewsAMPHAmphastar Pharmaceuticals4.2439 of 5 stars$24.34+1.0%$32.33+32.8%-42.4%$1.16B$731.97M8.111,620OCULOcular Therapeutix4.2252 of 5 stars$7.39+4.7%$16.25+119.9%+19.7%$1.12B$59.65M-5.60230Gap UpBGMQilian International Holding GroupN/A$11.42+3.5%N/AN/A$1.11B$25.10M0.00298Positive NewsGap UpAUPHAurinia Pharmaceuticals2.4223 of 5 stars$8.12+1.5%$11.50+41.6%+49.2%$1.11B$235.13M-54.13300WVEWave Life Sciences4.367 of 5 stars$6.60+0.2%$21.17+220.7%-4.4%$1.02B$108.30M-5.95240Positive NewsGap DownGYREGyre Therapeutics0.2783 of 5 stars$10.83+13.6%N/A-20.8%$1.02B$105.76M541.5040 Related Companies and Tools Related Companies ANI Pharmaceuticals Competitors ARS Pharmaceuticals Competitors Calliditas Therapeutics AB (publ) Competitors 89bio Competitors Amphastar Pharmaceuticals Competitors Ocular Therapeutix Competitors Qilian International Holding Group Competitors Aurinia Pharmaceuticals Competitors Wave Life Sciences Competitors Gyre Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CKPT) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Checkpoint Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Checkpoint Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
